ICARES Medicus, Inc. (TPEX: 6612)

Market Cap	6.53B
Revenue (ttm)	645.00M
Net Income (ttm)	70.35M
Shares Out	43.08M
EPS (ttm)	1.71
PE Ratio	88.78
Forward PE	n/a
Dividend	0.18 (0.13%)
Ex-Dividend Date	Jul 8, 2024

Volume	885,528
Open	152.50
Previous Close	145.00
Day's Range	151.50 - 159.50
52-Week Range	96.36 - 174.50
Beta	0.65
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2024

About ICARES Medicus

ICARES Medicus, Inc., a nano-medical material company, focuses on the research and development, manufacture, and sale of ophthalmic medical materials in Taiwan and internationally. It provides ophthalmic medical materials, including intraocular lens for the treatment of cataract, myopia, hyperopia, presbyopia, or astigmatism; and surgical implantation systems, as well as related technical services. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2011
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6612

Financial Performance

In 2023, ICARES Medicus's revenue was 605.45 million, an increase of 18.29% compared to the previous year's 511.85 million. Earnings were 97.73 million, a decrease of -24.19%.